Gut bacteria in people with type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at the bacteria in your gut (microbiome) to see if people with type 1 diabetes who have complications have different bacteria than those without complications. You'll be asked to give stool and urine samples
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older and have type 1 diabetes.
- Your diagnosis of type 1 diabetes was made by your doctor before the study visit.
- You are able to provide samples of stool (feces) and urine.
- You have not smoked or used recreational drugs (like ecstasy, amphetamines, cocaine, heroin, or GHB) in the past 3 months and are willing not to use them during the study.
- You do not have an active infection at the time of the study visit.
- You have not had your large bowel removed (you do not have a colostomy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune (defense system) and blood-sugar changes in people with type 1 diabetes, and in some other diabetes or autoimmune hormone conditions. It includes people who will have a specific abdominal surgery so doctors can safely study lymph node tissue.
This study tests whether a special treatment aimed at gut bacteria can help children newly diagnosed with type 1 diabetes. It is for kids ages 6 to 12 who were diagnosed in the last 6 months and do not have other serious health conditions.
This trial studies whether taking prebiotics can change gut bacteria (gut microbiome) in people with type 1 diabetes. The goal is to see if these gut changes are linked to better health or diabetes-related outcomes.
This trial tests whether transplanting healthy bacteria into your gut can improve memory and thinking skills in people with long-term type 1 diabetes. If you have had type 1 diabetes for 10 years or more, this study may help find a new way to protect your brain.
This study is looking at how a sugar-processing protein, called GLUT1, affects the immune system in people with type 1 diabetes. It uses blood samples already stored in a biobank, so no new samples or treatments are needed from you.
This Phase 2 study looks at the gut microbiome (the bacteria in your intestines) in youth with type 1 diabetes, and how metformin may work differently through the gut. It may help researchers understand mechanisms and future treatment options.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.